Your session is about to expire
← Back to Search
ASLAN004 for Atopic Dermatitis
Study Summary
This trial will test a new drug for people with moderate to severe atopic dermatitis. The study will have 5 groups, 4 of which will test different doses of the drug, and 1 will be given a placebo.
- Atopic Dermatitis
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have tried using creams containing corticosteroids or calcineurin inhibitors, but they didn't work well for you.Application of a consistent amount of topical emollient for at least 7 days prior to randomization.At least 10% BSA of AD involvement at Screening and Baseline.You have a vIGA score of ≥3 at Screening and Baseline.EASI score ≥16 at Screening and Baseline.You have used creams containing corticosteroids or calcineurin inhibitors before for your condition, but they did not work well.You have taken leukotriene inhibitors within the last 4 weeks before the study.You have a history of weakened immune system or serious infections caused by opportunistic germs.You have received a live vaccine within the past 8 weeks before the study.You have had a parasitic infection within the past 4 weeks or have traveled to areas with a high risk of parasites within the past 3 months.You have been diagnosed with AD for at least a year.Your skin condition, as measured by the EASI score, is severe with a score of 16 or higher.
- Group 1: Placebo every two weeks q2w
- Group 2: ASLAN004 400 mg every four weeks q4w
- Group 3: ASLAN004 300 mg q2w
- Group 4: ASLAN004 400 mg q2w
- Group 5: ASLAN004 600 mg q4w
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can patients still sign up for this clinical research project?
"Indeed, the clinical trial is still enrolling patients if they meet the requirements. The study was first posted on March 16th, 2022 and updated as recently as August 26th, 2022. They are looking for a total of 295 patients from 48 different locations."
Could you explain how many research facilities are involved in this project?
"DermEffects in London, ASLAN Investigative Site in Los Angeles, the Clinical Research Center of the Carolinas in Charleston, and 48 other locations across America are running this trial."
Has ASLAN004 received FDA approval for public consumption?
"ASLAN004 has undergone some safety testing and received a score of 2."
How many people are allowed to enroll in this research project?
"That is correct. The information available on clinicaltrials.gov indicates that this study posted on March 16th, 2022 and last updated on August 26th, 2022 is still recruiting participants. They are currently looking for 295 individuals at 48 different sites."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- MedDerm Associates: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger